5 Key Takeaways

• 1

  The ACP recommends biennial mammography for average-risk women aged 50 to 74, emphasizing shared decision-making for those aged 40 to 49 and 75 or older.

• 2

  For women aged 40 to 49, the ACP advises individualized screening discussions due to minimal mortality benefits and potential harms associated with routine screening.

• 3

  The ACP suggests considering digital breast tomosynthesis for patients with dense breasts but does not recommend supplemental MRI or ultrasound for average-risk individuals.

• 4

  Patients aged 75 and older should discuss discontinuing screening, as evidence shows no clear mortality benefit and increased risks of overdiagnosis.

• 5

  The ACP highlights the importance of assessing individual risk and ensuring participation in high-quality screening programs to optimize outcomes.